NCI R61: Early-Stage Development of Innovative Tech for Cancer Research (No Clinical Trials Allowed)
The National Cancer Institute invites R61 grant applications to develop early-stage, proof-of-concept technologies that improve molecular or cellular characterization of cancer or the handling and quality control of cancer biospecimens. Projects must focus on cancer-relevant use cases and demonstrate technical feasibility, not hypothesis-driven research using existing tools. Clinical trials ar…
Source
Award
Dates
Eligibility
Keywords
Supporting Links
Documents
Similar Opportunities
Get the full picture on this opportunity
Create a free Scout account to unlock everything you need to decide fast and win the grant.
-
Instant Fit Analysis
Let our grant expert AI score how well this opportunity aligns with your organization, strengths, gaps, and how to improve your chances of winning funding.
-
Deep agency & funder detail
Program context, sub-agency structure, and a full eligibility breakdown.
-
Source links & full documents
Jump straight to the solicitation and download every attachment.
-
Similar opportunities
Discover related funding matched to your work.
Already have an account? Sign In
Trusted by 500+ Happy Customers